More than a hundred influential doctors banded together to propose seven ways to bring down the high prices of cancer drugs. They say changes are needed to preserve access to care.
One doctor rethinks his hardline stance against contact with industry. Beyond drugmakers' sales and marketing, perhaps there's room for productive and ethical collaboration to advance medicine.
The House of Representatives has approved a bill that would increase National Institutes of Health funding and ease rules for the approval of new drugs. But the Senate may not go along.
The latest data on payments from drug and device companies to doctors show that many doctors received payments on 100 or more days last year. Some received payments on more days than they didn't.
The latest data on drug and device company payments to health professionals largely exclude nurse practitioners and physician assistants, even though they play an increasing role in patient care.
Proponents claim the Food and Drug Administration is applying a double standard to its review of a drug some call the female Viagra. Critics say flibanserin hasn't been proved safe or effective.
Federal officials released prescription histories of hundreds of thousands of doctors and identified the most common and costly drugs. Medicare spent the most on a purple pill for heartburn.
Eye drops are unpleasant, and they don't do a great job of delivering medication to the eye. A superthin wafer that slowly dispenses medication and then dissolves is a promising replacement.